Amgen is one ofthe world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Serves as the central hub for global operations, corporate leadership, research and development (R&D) strategy, and administrative functions.
A sprawling, modern campus featuring state-of-the-art research laboratories, advanced office buildings, and employee amenities such as fitness centers, cafes, and extensive green spaces. The campus design often emphasizes sustainability and collaboration.
Characterized by a strong emphasis on scientific innovation, collaboration across disciplines, and a patient-centric mission. Employees often describe a dynamic and intellectually stimulating environment with opportunities for growth and development.
The Thousand Oaks headquarters is strategically important as the nerve center for Amgen's worldwide operations, guiding its research priorities, business development, and corporate strategy. It also represents Amgen's origins and sustained leadership in the biotechnology industry.
Amgen maintains a significant global presence, operating in approximately 100 countries across North America, South America, Europe, Asia, Australia, and the Middle East. This worldwide network supports a wide range of functions including research and development, manufacturing, clinical trials, commercial operations, sales and marketing, and distribution of its innovative medicines to patients globally.
One Amgen Center Drive
Thousand Oaks
California
USA
Address: Granta Park, Great Abington, Cambridge, CB21 6GS, UK
Drives Amgen's R&D efforts in Europe, fostering collaborations with academic institutions and biotech companies in the region.
Address: Minervum 7061, 4817 ZK Breda, Netherlands
Critical for Amgen's supply chain and commercial operations across Europe, the Middle East, and Africa (EMEA).
Address: Road 31, Km 24.6, Juncos, PR 00777, USA
A vital part of Amgen's global manufacturing network, ensuring reliable supply of complex therapies and benefiting from Puerto Rico's established pharmaceutical manufacturing expertise.
Address: 216 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA and Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH, UK
Manages the commercialization and availability of Amgen's products within the UK and Irish healthcare systems.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Amgen' leadership includes:
Amgen has been backed by several prominent investors over the years, including:
In the past year, Amgen announced a key leadership transition in its Research and Development division. Other top executive roles have remained stable.
Discover the tools Amgen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Amgen commonly uses the email format combining the first initial and last name of the employee. Variations may exist, but this is a widely observed pattern.
[first_initial][last]@amgen.com
Format
jdoe@amgen.com
Example
85%
Success rate
Amgen Press Release • May 2, 2024
Amgen announced its financial results for the first quarter of 2024, reporting total revenues of $7.4 billion, a 22% increase compared to the first quarter of 2023, primarily driven by the Horizon Therapeutics acquisition and growth in key products....more
Amgen Press Release • May 19, 2024
New data presented at the ATS 2024 International Conference showed Tezspire (tezepelumab) consistently reduced asthma exacerbations requiring emergency room visits or hospitalization across a broad population of severe asthma patients....more
Amgen Press Release • March 5, 2024
Amgen announced that David M. Reese, M.D., executive vice president, Research and Development, intends to retire at the end of 2024. Jay Bradner, M.D., will join Amgen as chief scientific officer and executive vice president, Research and Development, effective early 2025....more
Amgen Press Release • January 29, 2024
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved BEKEMV™ (eculizumab-aeeb), a biosimilar to Soliris® (eculizumab), for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Amgen, are just a search away.